Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model.

Digital data available（奈良県立医科大学機関リポジトリ GINMU）

学術機関リポジトリデータベース（IRDB）（機関リポジトリ）

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model.

Material type: 博士論文

Author: Kubo, Takuyaほか

Publisher: Biomedical Research Network+

Publication date: 2019-12

Material Format: Digital

Capacity, size, etc.: -

Name of awarding university/degree: 奈良県立医科大学,博士（医学）

View All

Notes on use

Note (General)：: type:ThesisInflammation and oxidative stress contribute to the progression of nonalcoholic steatohepatitis (NASH). Hepatic fibrosis and activated hepa...

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

GINMU :Global Institutional repository of Nara Medical University
Digital
You can check the holdings of institutions and databases with which Institutional Repositories DataBase(IRDB)(Institutional Repository) is linked at the site of Institutional Repositories DataBase(IRDB)(Institutional Repository).
GINMU :Global Institutional repository of Nara Medical University

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 博士論文
Title: Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model.
Author/Editor: Kubo, Takuya
Kawaratani, Hideto
Sawada, Yasuhiko
Fujinaga, Yukihisa
Ozutsumi, Takahiro
Kaya, Daisuke
Tsuji, Yuki
Nakanishi, Keisuke
Furukawa, Masanori
Kitagawa, Kou
Saikawa, Soichiro
Sato, Shinya
Takaya, Hiroaki
Kaji, Kosuke
Shimozato, Naotaka
Moriya, Kei
Namisaki, Tadashi
Akahane, Takemi
Mitoro, Akira
Yoshiji, Hitoshi
Author Heading: Kubo, Takuya
Kawaratani, Hideto
Sawada, Yasuhiko
Fujinaga, Yukihisa
Ozutsumi, Takahiro
Kaya, Daisuke
Tsuji, Yuki
Nakanishi, Keisuke
Furukawa, Masanori
Kitagawa, Kou
Saikawa, Soichiro
Sato, Shinya
Takaya, Hiroaki
Kaji, Kosuke
Shimozato, Naotaka
Moriya, Kei
Namisaki, Tadashi
Akahane, Takemi
Mitoro, Akira
Yoshiji, Hitoshi
Publication, Distribution, etc.: Biomedical Research Network+
Publication Date: 2019-12
Publication Date (W3CDTF): 2019-12
Alternative Title: L-カルニチンとアンギオテンシン-II1型受容体遮断薬の組み合わせは、非アルコール性脂肪肝炎ラットモデルにおける肝線維症に有益な効果を有する
Periodical title: Biomedical journal of scientific and technical research
No. or year of volume/issue: 23 5
Volume: 23
Issue: 5
Pages: 17787-17792
ISSN (Periodical Title): ISSN : 2574-1241
Degree grantor/type: 奈良県立医科大学
Date Granted: 2020-03-16
Dissertation Number: 甲第736号
Degree Type: 博士（医学）
Text Language Code: eng
Subject Heading: Angiotensin-2 type 1 Receptor Blocker
L-carnitine
Nonalcoholic Steatohepatitis
Hepatic Fibrosis
Oxidative Stress
Target Audience: 一般
Note (General): type:Thesis
Inflammation and oxidative stress contribute to the progression of nonalcoholic steatohepatitis (NASH). Hepatic fibrosis and activated hepatic stellate cells (Ac-HSCs) are attenuated by Angiotensin-II type 1 Receptor Blocker (ARB), and L-carnitine is effective for NASH by ameliorating oxidative stress, but neither agent is effective in a clinical setting. We evaluated the effect of the combination of L-carnitine and ARB on liver fibrosis using a rat NASH model. A Choline-Deficient/L-Amino Acid-defined (CDAA) diet was fed to F344 rats for 8 weeks. The rats were then divided into a control group, group receiving L-carnitine or ARB alone, and group receiving L-carnitine plus ARB. Therapeutic efficacy was assessed by evaluating liver fibrosis, liver fatty acid metabolism, and oxidative stress. ARB inhibited liver-specific tumor necrotic factor-α and LPS-binding protein, which are involved in hepatic inflammation. L-Carnitine reduced hepatic oxidative stress by rescuing hepatic sterol-regulatory elementbinding protein 1 and thiobarbituric acid reactive substances induced by the CDAA diet. Combination of L-carnitine and ARB improved liver fibrosis, with concomitant HSC suppression. Therefore, we suggest that L-carnitine and ARB are effective in suppressing liver fibrosis. Currently both drugs are in clinical use, and a combination of the two could be an effective therapy for NASH fibrosis.
博士（医学）・甲第736号・令和2年3月16日
Copyright © 2019 Hideto Kawaratani, Biomed J Sci & Tech Res. This is an openaccess article distributed under the terms of the Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/).
identifier:Biomedical journal of scientific and technical research Vol.23 No.5 p.17787-17792 (2019 Dec)
identifier:25741241
identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3727
identifier:Biomedical journal of scientific and technical research, 23(5): 17787-17792
Source: fulltext
http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3727/1/01%e7%94%b2736%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf
fulltext
http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3727/2/02%e7%94%b2736%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf
fulltext
http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3727/3/03%e7%94%b2736%e6%9c%ac%e6%96%87.pdf
Access Restrictions: インターネット公開
Related Material (DOI): 10.26717/BJSTR.2019.23.003969
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU